Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Bpifrance Investissement Sas, Director. Director active across 22 companies, notably MAAT PHARMA. In total, 108 filings have been recorded. Breakdown: 18 buys · 45 sells. Total volume traded: €778.6m. Activity tracked since 8 February 2021. The latest transaction was disclosed on 24 July 2026 (Réalisation de l'apport de 53 985 AO VOYAGEURS DU MONDE déte). Regulator: AMF. All data is openly available.
Companies and markets linked to Bpifrance Investissement Sas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
37,808 shares@ €26.480.3% of flowActionEuronext ParisISINISIN FR00116753622024DD969043
25 of 108 declarations
About Bpifrance Investissement Sas
BPIFRANCE INVESTISSEMENT SAS is a management company, director or censeur representing Bpifrance Investissement SAS. It has 104 filings in total, and, for the most recent sampled filings, the transactions run from 2021-12-08 to 2026-07-10, with buy volume of EUR 307327072 and sell volume of EUR 731141878. Among the largest filings are a sale in NEOEN for EUR 265977629.5, a sale in ELIS for EUR 160494000, and a sale in SPIE SA for EUR 126000000.